Quintiles Honored for IT Innovation, Named to 2014 CIO 100

2014.06.09 20:37:40

[By NBC-1TV H. J Yook]Quintiles, the world’s largest biopharmaceutical services provider, has been named to the 2014 CIO 100. Each year, CIO magazine identifies and honors 100 organizations that have distinguished themselves by creating business value through the effective and innovative use of IT.

Quintiles was named to the CIO 100 because of its transformational Quintiles Infosario® Safety solution, a drug safety technology platform which is fully integrated with relevant regulatory agencies and future-proofed through a community development model.

“We are honored to be included in the CIO 100 for our work in helping to solve industry and customer challenges,” said Quintiles CIO Richard Thomas. “Introduced in 2011, our award-winning Infosario solutions combine our deep scientific and operational expertise with industry-leading technology innovations that improve our customers’ probability of success at every step of the way.”

During development of Quintiles Infosario Safety, the company consolidated more than 35 individual drug safety systems and pooled a wide range of best practices and processes to create a highly optimized and efficient operating model to help its biopharmaceutical customers ensure that all regulatory requirements for drug safety management are met on a global basis. Quintiles then developed an entire portfolio of safety applications, regulatory agency integrations and implementation accelerators virtualized and deployed in its private cloud, securely available 24 hours a day, seven days a week via web browser.


By H. J Yook hjyook@nbc1tv.com
< 저작권자 © NBC-1TV , 무단전재 및 재배포금지 >







PC버전으로 보기


주소 : 서울특별시 영등포구 여의도동 17-20번지 원정빌딩 4층(KBS 본관 옆)
Add : Rm. 401 Won-Jeong Building, #17-20. Yoido-Dong, Youngdeungpo
-Gu, Seoul, Korea | Tel : 82-2-6414-6114 | Fax : 82-2-761-3114 |
대표전화 : 02-6414-6114 | 팩스 : 02-761-3114 | 보도국 당직 : 010-3329-6114
E-mail : korea@nbc1tv.com | seoul@nbc1tv.com
Copyright ⓒ 2007 NBC-1TV News Beyond Cliche All rights reserved.